ITMCTR2100004816招募中1 期
Efficacy and Safety of Zhitan Anshen Granules in Motor Dysfunction After Cerebral Infarction: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Hubei Provincial Hospital of Integrated Chinese and Western Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 75（—）
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria for cerebral infarction, and be confirmed by head CT or MRI;
- •2. Meet the standard of Chinese medicine stroke-qi deficiency and blood stasis syndrome type;
- •3. In the recovery period (the course of illness is between 2 weeks and 6 months)
- •4. Aged 40 to 75 years;
- •5. First stroke, stable vital signs, clear consciousness, able to cooperate with examination and treatment;
- •6. Having motor dysfunction and Fugl-Meyer score <= 84 points;
- •7. Sign the informed consent form.
排除标准
- •1. Patients with severe cardiovascular, cerebrovascular, liver, kidney, malignant tumors, hematological diseases, and mental diseases;
- •2. Severe disturbance of consciousness, dementia or suffering from certain diseases affect the evaluation of curative effects, such as aphasia, visual and hearing impairment;
- •3. Transient organic psychosis and other mental illnesses (such as depression, schizophrenia), or other mental disorders that meet the DSM-IV-R standards;
- •4. Patients who have other diseases that affect the function of limbs, and those who have dysfunction of limbs caused by claudication, osteoarthritis, rheumatoid arthritis, gouty arthritis, etc. before treatment may affect nerve or functional examination;
- •5. Patients who are allergic to test drug components, or have a history of alcohol or drug abuse;
- •6. Women who are pregnant or breastfeeding, or have a pregnancy plan in the past 6 months, or cannot use effective contraceptive measures (sterilization, long-term use of contraceptives/drugs, condoms, or removal of the vas deferens from their partners, etc.);
- •7. Participating in other clinical trials or participating in other drug clinical trials within 3 months.
- •8. Patients judged by the investigator to be unsuitable to participate in this trial.
研究者
相似试验
招募中
1 期
Efficacy and Safety of Zhitan Anshen Granules in Cognitive Impairment After Cerebral Infarction: a Randomized, Double-Blind, Placebo-Controlled Clinical TrialCerebral InfarctionITMCTR2100004803Hubei Provincial Hospital of Integrated Chinese and Western Medicine
招募中
4 期
Safety and efficacy of Shaoma Zhijing granule in the treatment of tic disorder in children: a multicenter phase IV clinical trialTic DisorderITMCTR2200005755Jiangsu Hospital of traditional Chinese Medicine, Beijing Anding Hospital Affiliated to Capital Medical University
尚未招募
4 期
The efficacy and safety of Jingfang Granules in treating air-conditioning diseasesThe Disease of Air ConditioningITMCTR2000003664Zhangjiagang Hospital of Traditional Chinese Medicine
招募中
不适用
Clinical study of Anshenjianpizhiyang granule's curative effect and improvement degree of life quality to children with atopic dermatitisAtopic dermatitisITMCTR2100004594Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine
尚未招募
4 期
Efficacy and safety of Xingbei Zhike granules in treatment of post-infectious cough (Wind-heat Invading the Lung Syndrome): A multicenter, randomized, double-blind, placebo-controlled trialpost-infectious coughITMCTR2000004063Guangdong Province Hospital of Traditional Chinese Medicine